Press Room

2021 Online Booth

Start
Thursday, September 30, 2021 - 00:00
End
Saturday, October 30, 2021 - 00:00
Location: online
Hovione Virtual Stand 2021 Online Booth | Hovione

Meet our experts at the pharma industry-leading events

 

We attend the leading events of the pharma industry throughout the year to present our Services & Products, sharing our scientists' innovative work.

Count on our multidisciplinary teams to understand, develop and improve your project. As a specialist integrated CDMO we are dedicated to helping you bring new and off-patent drugs to market faster.

Schedule an in-person meeting or virtual conversation beforehand and find out how we can support your project.

 

 

Hovione at a Glance | Hovione

Get to know more about our history

e-Brochures | Hovione

Explore what we do

Integrated CDMO | Hovione

Webinars, Articles & More

Cork Site | Hovione

We welcome you to our sites

Events | Hovione

Events will be attending

Analytical Development | Hovione

Our experts will help you

 

 

SOLVING YOUR CHALLENGES

Read the article from C&EN "One molecule’s journey from discovery to market" to find out how Hovione helped one customer solve their problem and succeed. More case studies will be available soon.

 

 

Subscribe to our newsletter and be the first to know.

 

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025